Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 1807 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Can-Fite Signs MOU With Morningside

The Morningside fund, in the amount of $7.5m, will provide all the required funding needed for the pre-clinical and clinical development plans up to the completion of phase